EN
HI
Valiant Laboratories Chart
Valiant Laboratories Share Key Metrics
Volume
2.22 L
Market Cap
436.18 CR
LTQ@LTP
200@80.31
ATP
78.12
Var Margin
100 %
Circuit Range
73.57-81.31
Delivery %
0 %
Value
1.74 CR
ASM/GSM
No
Market Lot
1
Summary
Valiant Laboratories share price is ₹80.31 as of 2 Jun, 2026. The stock Valiant Laboratories intraday movement has stayed between ₹76.00 and ₹81.30, while on a 52-week basis,Valiant Laboratories price 52 week high is ₹115.19 & its 52 week low is ₹49.51.
In terms of trading activity, Valiant Laboratories has recorded a volume of 222308 shares, The Valiant Laboratories has a market cap of ₹54312500 CR. The stock’s Average Traded Price (ATP) stands at ₹78.12, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 200 @ ₹80.31.
Valiant Laboratories operates within a circuit range of ₹73.57 – ₹81.31, with a Value of ₹1.74 CR. The Delivery Percentage for the day is 0%. Additionally, Valiant Laboratories currently falls under the No framework, and trades with a market lot size of 1.
Valiant Laboratories Fundamentals
View MoreP/E Ratio
0
P/B Ratio
1.36
Div. Yield
0
Sector P/E
69.53
Sector P/B
2.99
Sec. Div. Yield
0.55
Valiant Laboratories Resistance and Support
Pivot 78.15
Resistance
First Resistance
79.3
Second Resistance
81.17
Third Resistance
82.32
Support
First Support
76.28
Second Support
75.13
Third Support
73.26
Valiant Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-14 | Audited Results |
| 2025-05-20 | Audited Results |
Valiant Laboratories News
Valiant Laboratories Ltd - 543998 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
Valiant Organics Limited, a promoter group entity of Valiant Laboratories, announced the acquisition of 1.86 crore equity shares, representing a 34.26% stake, from Dhanvallabh Ventures LLP through an off-market transaction. This move is part of a larger internal restructuring exercise.
May 20 2026 10:13:25
Valiant Laboratories Limited
Valiant Laboratories Limited announced a proposed inter-se transfer of 18.6 million equity shares (34.26% of total capital) between promoter entities Dhanvallabh Ventures LLP and Valiant Organics Limited. This internal transfer is part of a restructuring exercise by the promoter group.
May 19 2026 23:53:38
Read More
Valiant Laboratories Management
| Name | Position |
|---|---|
| Mulesh M Savla | Non Executive Independent Director |
| Santosh S Vora | Managing Director |
Valiant Laboratories Similar Stocks
Valiant Laboratories FAQs
The Buying Price of Valiant Laboratories share is 80.31 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Valiant Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Valiant Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Valiant Laboratories shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Valiant Laboratories shares is 1.36. Useful to assess the stock's value relative to its book value.
To assess Valiant Laboratories’s valuation compare Sector P/E, P/B which are 69.53 & 2.99 with sector averages, along with growth rates and financial metrics.
The Market Cap of Valiant Laboratories is 436.18 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Valiant Laboratories share price is 115.19 & 49.51. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Valiant Laboratories belongs to the Healthcare sector.
